Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2012 (Vol. 32, No. 1)

Tapping the Expertise of Oncology CROs

  • Cancer drug development is perhaps the most arduous task faced by the drug industry today with technically difficult, time-consuming, and expensive clinical trials constituting the lion’s share of that challenge. Merely handling the logistics of the trials—how and where they should be conducted, recruiting patients, and monitoring the sites—can ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.